Sanofi (SNYNF) Stock Price, News & Analysis

Company Overview

Sanofi is a global pharmaceutical and healthcare company headquartered in Paris, France. The company researches, develops, manufactures and markets prescription medicines and vaccines for patients in markets around the world.

Its principal business areas include immunology, rare diseases, neurology, oncology, rare blood disorders and vaccines. Sanofi’s products include Dupixent, a biologic used to treat several inflammatory conditions; established medicines for specialty-care and general-care indications; and vaccines marketed through its Vaccines division, including products for influenza, polio, meningitis and travel-related diseases.

Sanofi was created in 2004 through the merger of Sanofi-Synthélabo and Aventis, bringing together businesses with roots in several European pharmaceutical companies. The company serves healthcare providers, governments and patients across North America, Europe, emerging markets and other international regions. Paul Hudson has served as Sanofi’s chief executive officer since 2019.

Key Stats

• Today's Range: $84.81 to $84.82
• 50-Day Range: $76.76 to $93.45
• 52-Week Range: $76.76 to $106.34
• Volume: 1,394 shs
• Average Volume: 25,694 shs
• Market Capitalization: N/A
• P/E Ratio: 27.50
• Dividend Yield: 3.30%
• Price Target: N/A
• Consensus Rating: N/A

Sanofi Stock Analysis - MarketRank™

Sanofi scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Sanofi.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sanofi is 27.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.81.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sanofi is 27.50, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.70.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Sanofi has a short interest ratio ("days to cover") of 42.73, which indicates bearish sentiment.

Change versus previous month

Short interest in Sanofi has recently decreased by 20.90%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Sanofi is a leading dividend payer. It pays a dividend yield of 4.13%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Sanofi does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sanofi is 90.78%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Sanofi this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sanofi insiders have not sold or bought any company stock.

Percentage Held by Institutions

30.06% of the stock of Sanofi is held by institutions.

Company Calendar

• Today: 10/26/2026
• Next Earnings (Estimated): 10/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:SNYNF
• CIK: 1121404
• Web: www.sanofi.com
• Phone: (315) 377-4000
• Fax: N/A
• Employees: 76,493
• Year Founded: 2004

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 27.50
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A